secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiniksa Pharmaceuticals International, plc (KNSA)
CIK:        0001730430
Form:       8-K
Filed at:   2024-10-07T23:59:59+00:00
Accession:  0001104659-24-106690
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kiniksa appoints M. Cantey Boyd to Board, increasing size to 10 directors
-------------------------------------------------------------------------

- Board size increased from 9 to 10; Boyd appointed as Class III director.
- Boyd is a Managing Director at Baker Bros. Advisors LP, a life sciences investment firm.
- She will serve on Compensation Committee; receives standard non-employee director compensation.
- No material transactions between Boyd and the company; standard indemnification agreement entered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730430/000110465924106690/0001104659-24-106690-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730430/000110465924106690/tm2425633d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-106690

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer